{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:54:47Z","timestamp":1777859687427,"version":"3.51.4"},"reference-count":18,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T00:00:00Z","timestamp":1563667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Guidelines support statin therapy post-stroke or transient ischemic attack (TIA); however, previously reported utilization rates are suboptimal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study investigates the incidence of statin usage in patients with a documented stroke or TIA while identifying predictors of statin use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective, cross-sectional study utilizing data from the National Ambulatory Medical Care Survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 2963 unweighted visits were included in the analysis, representing a total of 52 645 000 office visits when weighted. Statin therapy was initiated or continued in 35.7% (95% confidence interval [CI]: 32.4-39.0%) of office visits. Upon multivariate analysis, positive predictors of statin therapy included a diagnosis of hyperlipidemia (odds ratio [OR]: 3.60; 95% CI: 2.40-5.41), angiotensin-converting enzyme inhibitor (ACE-I) therapy (OR: 2.52; 95% CI: 1.69-3.76), aspirin therapy (OR: 2.02; 95% CI: 1.40-2.93), and clopidogrel therapy (OR: 2.60; 95% CI: 1.69-4.02). Negative predictors of statin therapy included office visits with neurologists when compared to visits with primary care practitioners (OR: 0.55; 95% CI: 0.33-0.90) and office visits in rural areas when compared to office visits in urban areas (OR: 0.64; 95% CI: 0.41-0.99).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Various factors impact statin therapy use with overall utilization being suboptimal, highlighting an opportunity for medication optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0897190019865147","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:07:22Z","timestamp":1563754042000},"page":"216-223","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["National Trends in Statin Medication Prescribing in Patients With a History of Stroke or Transient Ischemic Attack"],"prefix":"10.1177","volume":"34","author":[{"given":"Brittany M.","family":"Snyder","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University Hospitals Geauga Medical Center, Chardon, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7657-3399","authenticated-orcid":false,"given":"Mate M.","family":"Soric","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University Hospitals Geauga Medical Center, Chardon, OH, USA"},{"name":"Department of Pharmacy Practice, Northeast Ohio Medical University College of Pharmacy, Rootstown, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,7,21]]},"reference":[{"key":"bibr1-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000152"},{"key":"bibr2-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000485"},{"key":"bibr3-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024"},{"key":"bibr4-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061894"},{"key":"bibr5-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"bibr6-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005523"},{"key":"bibr7-0897190019865147","unstructured":"National Ambulatory Medical Care Survey public-use files and documentation. [article online], 2010. Accessed July 15, 2015. http:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_estimation_reliability.htm."},{"key":"bibr8-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11375"},{"key":"bibr9-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437738.63853.7a"},{"key":"bibr10-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.12.010"},{"key":"bibr11-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1341"},{"key":"bibr12-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3670"},{"key":"bibr13-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3608"},{"key":"bibr14-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646"},{"key":"bibr15-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4020"},{"key":"bibr16-0897190019865147","unstructured":"FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs [article online], 2012. Accessed January 7, 2019. https:\/\/www.fda.gov\/drugs\/drugsafety\/ucm293101.htm."},{"key":"bibr17-0897190019865147","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-014-3115-3"},{"key":"bibr18-0897190019865147","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2014099"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190019865147","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190019865147","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190019865147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:35:38Z","timestamp":1777509338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190019865147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,21]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1177\/0897190019865147"],"URL":"https:\/\/doi.org\/10.1177\/0897190019865147","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,21]]}}}